Cas 876372-30-4,Benzoic acid, 3-[6-[2-(2,4-difluorophenyl)ethyl]-1,2,4-triazolo[4,3-a]pyridin-3-yl]-4-meth yl-, methyl ester

876372-30-4

Post Buying Request

Basic information

Product Name: Benzoic acid, 3-[6-[2-(2,4-difluorophenyl)ethyl]-1,2,4-triazolo[4,3-a]pyridin-3-yl]-4-meth yl-, methyl ester
Synonyms:
CAS NO:876372-30-4
Molecular Formula: C23H19F2N3O2
Molecular Weight:
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzoic acid, 3-[6-[2-(2,4-difluorophenyl)ethyl]-1,2,4-triazolo[4,3-a]pyridin-3-yl]-4-meth yl-, methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Benzoic acid, 3-[6-[2-(2,4-difluorophenyl)ethyl]-1,2,4-triazolo[4,3-a]pyridin-3-yl]-4-meth yl-, methyl ester(876372-30-4)
EPA Substance Registry System: Benzoic acid, 3-[6-[2-(2,4-difluorophenyl)ethyl]-1,2,4-triazolo[4,3-a]pyridin-3-yl]-4-meth yl-, methyl ester(876372-30-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 876372-30-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

876372-30-4 Suppliers

Recommended suppliers

876372-30-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 876372-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,3,7 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 876372-30:
(8*8)+(7*7)+(6*6)+(5*3)+(4*7)+(3*2)+(2*3)+(1*0)=204
204 % 10 = 4
So 876372-30-4 is a valid CAS Registry Number.

876372-30-4Upstream product

876372-30-4Downstream Products

876372-34-8 3-{6-[2-(2,4-difluorophenyl)ethyl][1,2,4]triazolo[4,3-a]pyridin-3-yl}-4-methylbenzoic acid

876372-30-4Relevant academic research and scientific papers

Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition

Jerome, Kevin D.,Rucker, Paul V.,Xing, Li,Shieh, Huey S.,Baldus, John E.,Selness, Shaun R.,Letavic, Michael A.,Braganza, John F.,McClure, Kim F.

scheme or table, p. 469 - 473 (2010/04/05)

The structure based drug design, synthesis and structure-activity relationship of a series of C6 sulfur linked triazolopyridine based p38 inhibitors are described. The metabolic deficiencies of this series were overcome through changes in the C6 linker fr

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 876372-30-4